FDDNP
Suspected Chronic Traumatic Encephalopathy (CTE) or Traumatic Encephalopathy Syndrome (TES)
University of California, Los AngelesSmall moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Suspected Chronic Traumatic Encephalopathy (CTE) or Traumatic Encephalopathy Syndrome (TES) cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
FLORTAUCIPIR Molecular NeuroImaging | Phase 1 | CC |
GOSURANEMAB University of California, San Francisco | Phase 1 | CC |
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE University of Texas Southwestern Medical Center | Early Phase 1 | C |
Intranasal Auto-M2-Bfs Russian Academy of Medical Sciences | Phase 1/2 | NR |
Same molecule, other indications
FDDNP is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →